(Q57793454)

English

Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in a

article

In more languages

Statements

scholarly article

0 references

Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in a (English)

0 references

influenza vaccine

1 reference

based on heuristic

Joanne M. Langley

object named as

Joanne M. Langley

9

0 references

Scott A Halperin

10

object named as

Scott A. Halperin

0 references

Shelly A McNeil

1

object named as

Shelly A. McNeil

0 references

author name string

Francisco Noya

2

0 references

Marc Dionne

3

0 references

Gerald Predy

4

0 references

William Meekison

5

0 references

Cecil Ojah

6

0 references

Santiago Ferro

7

0 references

Elaine L. Mills

8

0 references

language of work or name

0 references

publication date

April 2007

0 references

number of pages

11

1 reference

based on heuristic

inferred from page(s)

0 references

25

0 references

17

0 references

3464-3474

0 references

The changing age and seasonal profile of pertussis in Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Morbidity of pertussis in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis in adults: frequency of transmission after household exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis infection in adults with persistent cough

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Symptoms and complications of pertussis in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis in German adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Outbreak of pertussis in highly immunized adolescents and its secondary spread to their families.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Outbreak of pertussis in a fully immunized adolescent and adult population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis infection among adults during the 1993 outbreak in Chicago

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Frequency of unrecognized Bordetella pertussis infections in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Prevalence and incidence of adult pertussis in an urban population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Epidemiological, clinical, and laboratory aspects of pertussis in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis immunization for adolescents: What are we waiting for?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis is a frequent cause of prolonged cough illness in adults and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Evaluation of pertussis in U.S. Marine Corps trainees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991‐1997: Report of the Immunization Monitoring Program–Active (IMPACT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Efficacy of an acellular pertussis vaccine among adolescents and adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

A search for Bordetella pertussis infection in university students

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Pertussis and its prevention: a family affair

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Infant pertussis: who was the source?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Cellular and acellular pertussis vaccines in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Controlled study of a new five-component acellular pertussis vaccine in adults and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Effectiveness of influenza vaccine in health care professionals: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Summary of Clinical Trials of Inactivated Influenza Vaccine--1978

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.047

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.12.047

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57793454&oldid=1998107144"